Phenylimino-2H-chromen-3-carboxamide derivatives as novel small molecule inhibitors of β-secretase (BACE1).

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Bioorganic & Medicinal Chemistry

• Publication date

  2013-04-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmc.2013.01.064PMID 23480856
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel coumarin derivatives bearing N-benzyl pyridinium moiety: potent and dual binding site acetylcholinesterase inhibitors.

  2012cited by this paper
• Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)

  2012cited by this paper
• Developing β‐secretase inhibitors for treatment of Alzheimer’s disease

  2012cited by this paper
• Synthesis, Cytotoxicity, and QSAR Study of New Aza‐cyclopenta[b]fluorene‐1,9‐dione Derivatives

  2012cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Rational design and synthesis of aminopiperazinones as β-secretase (BACE) inhibitors.

  2011cited by this paper
• BACE inhibitors as potential drugs for the treatment of Alzheimer's disease: focus on bioactivity.

  2011cited by this paper
• Design, synthesis, and qualitative structure-activity evaluations of novel β-secretase inhibitors as potential Alzheimer's drug leads.

  2011cited by this paper
• Design, synthesis and anticholinesterase activity of a novel series of 1-benzyl-4-((6-alkoxy-3-oxobenzofuran-2(3H)-ylidene) methyl) pyridinium derivatives.

  2010cited by this paper
• CoMFA and molecular docking studies of benzoxazoles and benzothiazoles as CYP450 1A1 inhibitors.

  2010cited by this paper
• Progress in the development of beta-secretase inhibitors for Alzheimer's disease.

  2009cited by this paper
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility

  2009cited by this paper
• The β-Secretase Enzyme BACE in Health and Alzheimer's Disease: Regulation, Cell Biology, Function, and Therapeutic Potential

  2009cited by this paper
• Gamma-secretase inhibition and modulation for Alzheimer's disease.

  2008cited by this paper
• β-Secretase as a therapeutic target for Alzheimer’s disease

  2008cited by this paper
• 2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): Use of structure based design to convert a micromolar hit into a nanomolar lead.

  2007cited by this paper
• Naphthyl and coumarinyl biarylpiperazine derivatives as highly potent human beta-secretase inhibitors. Design, synthesis, and enzymatic BACE-1 and cell assays.

  2006cited by this paper
• Progress toward the discovery and development of efficacious BACE inhibitors.

  2006cited by this paper
• Similarities among receptor pockets and among compounds: analysis and application to in silico ligand screening.

  2005cited by this paper
• Economics of dementia and pharmacoeconomics of dementia therapy.

  2005cited by this paper
• RAPID MICROWAVE-ASSISTED SOLUTION PHASE SYNTHESIS OF SUBSTITUTED 2-PYRIDONE LIBRARIES

  2004cited by this paper
• Design and synthesis of statine-based cell-permeable peptidomimetic inhibitors of human beta-secretase.

  2003cited by this paper
• Crystal structure of memapsin 2 (beta-secretase) in complex with an inhibitor OM00-3.

  2002cited by this paper
• Beta-secretase as a therapeutic target for inhibitor drugs.

  2002cited by this paper
• Secretases as targets for the treatment of Alzheimer's disease: the prospects.

  2002cited by this paper
• Synthesis and antitumor activity of novel 2-amino-4-(3,5,5-trimethyl-2-pyrazolino)-1,3,5-triazine derivatives.

  2002cited by this paper
• Crystal Structure of Memapsin 2 (β-Secretase) in Complex with an Inhibitor OM00-3†

  2002cited by this paper
• Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation.

  2001cited by this paper
• Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation

  2001cited by this paper
• BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics.

  2001cited by this paper
• A New Pathway to 3-Hetaryl-2-oxo-2H-chromenes: On the Proposed Mechanisms for the Reaction of 3-Carbamoyl-2-iminochromenes with Dinucleophiles

  2000cited by this paper
• Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor.

  2000cited by this paper
• A novel and expedient approach to new heterocycles containing benzothiophene, benzothieno[2,3- d ]pyrimidine and coumarin moieties

  1999cited by this paper
• Purification and cloning of amyloid precursor protein β-secretase from human brain

  1999cited by this paper
• Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

  1998cited by this paper
• New derivatives of coumarin: 2-(N-R-imino)-2H-1-benzopyrans

  1994cited by this paper
• Reduction of Indigo: Sodium Hydrosulfite as a Reducing Agent

  1989cited by this paper
• Mechanism of the Reaction of Imido Esters with Amines

  1962cited by this paper
• Cyan-acethydrazid zur Darstellung von Stickstoff-Heterocyclen, II. 1-Acyl-3.5-dimethyl-pyrazole als Acylierungsmittel

  1958cited by this paper

• Design strategies, structural insights, and biological potential of amyloid-beta inhibitors in Alzheimer’s disease

  2025influential citation
• Montelukast's potential as a neuroprotective agent against acrylamide induced neurotoxicity: In vivo and computational modelling.

  2025cites this paper
• Synthesis and Spectral Studies of Iron‐Catalyzed Multicomponent Synthesis of 4‑Phosphorylated 4H‑Chromenes from 2‐Hydroxybenzyl Alcohols

  2025cites this paper
• Direct transition-metal-free synthesis of 2-heteroaryl-4-quinolones via ANRORC type rearrangement of 3-(2-(2-nitrophenyl)-2-oxoethyl)quinoxalin-2(1H)-ones.

  2025cites this paper
• Aminoquinazolin-4(3H)-one derivatives as multitargeting therapeutics in Alzheimer's disease

  2025cites this paper
• Sertraline as a Multi-Target Modulator of AChE, COX-2, BACE-1, and GSK-3β: Computational and In Vivo Studies

  2024cites this paper
• Screening Techniques for Drug Discovery in Alzheimer’s Disease

  2024cites this paper
• In Vivo and Computational Studies on Sitagliptin’s Neuroprotective Role in Type 2 Diabetes Mellitus: Implications for Alzheimer’s Disease

  2024cites this paper
• A Practical Synthesis of 2‐Arylimino‐2 H ‐Chromenes via Biocatalytic System in Water

  2023cites this paper
• Ru(II) catalyzed chelation assisted C(sp2)-H bond functionalization along with concomitant (4 + 2) annulation.

  2023cites this paper
• Discovery of Quinolinone Hybrids as Dual Inhibitors of Acetylcholinesterase and Aβ Aggregation for Alzheimer's Disease Therapy.

  2023cites this paper
• Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy.

  2022cites this paper
• Piperidine-Iodine as Efficient Dual Catalyst for the One-Pot, Three-Component Synthesis of Coumarin-3-Carboxamides

  2022cites this paper
• Metal-Free One-Pot Annulative Coupling of 2-Hydroxybenzaldehydes with β-Ketothioamides: Access to Diverse 2-Arylimino-2H-Chromenes.

  2022cites this paper
• BACE1: A Key Regulator in Alzheimer’s Disease Progression and Current Development of its Inhibitors

  2021cites this paper
• Dual targeting of acetylcholinesterase and tau aggregation: Design, synthesis and evaluation of multifunctional deoxyvasicinone analogues for Alzheimer's disease.

  2021cites this paper
• Imino‐2H‐Chromene Based Derivatives as Potential Anti‐Alzheimer's Agents: Design, Synthesis, Biological Evaluation and in Silico Study

  2021cites this paper
• Usage of Quantum Chemical Methods to Understand the Formation of Concomitant Polymorphs of Acetyl 2-(N-(2-Fluorophenyl)imino)coumarin-3-carboxamide

  2021cites this paper
• Coumarin linked heterocyclic hybrids: A promising approach to develop multi target drugs for Alzheimer's disease

  2021cites this paper
• Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.

  2020cites this paper
• Synthesis and In Vitro Biological Activity Evaluation of Novel Imidazo [2,1-B][1,3,4] Thiadiazole as Anti-Alzheimer Agents

  2020cites this paper
• One-pot Synthesis of Novel bisChroman-3, 4-dicarboxamides Containing Lipophilic Spacers

  2020cites this paper
• Anticholinesterase Activity of Cinnamic Acids Derivatives: In Vitro, In Vivo Biological Evaluation, and Docking Study

  2020cites this paper
• N-Cyclohexylimidazo[1,2-a]pyridine derivatives as multi-target-directed ligands for treatment of Alzheimer's disease.

  2020cites this paper
• Novel Deoxyvasicinone-Donepezil Hybrids as Potential Multitarget Drug Candidates for Alzheimer's Disease.

  2019cites this paper
• Challenges in the treatment of Alzheimer’s disease: recent progress and treatment strategies of pharmaceuticals targeting notable pathological factors

  2019cites this paper
• (NH4)42[MoVI72MoV60O372(CH3COO)30(H2O)72] as a Heterogeneous Reusable Catalyst for Organic Reactions: Mini-Review

  2019cites this paper
• 5,6-Diphenyl triazine-thio methyl triazole hybrid as a new Alzheimer’s disease modifying agents

  2019cites this paper
• Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases.

  2019cites this paper
• Synthesis and Cyclizations of N-(Thieno[2,3-b]pyridin-3-yl)cyanoacetamides

  2019cites this paper
• Multi-target inhibitors against Alzheimer disease derived from 3-hydrazinyl 1,2,4-triazine scaffold containing pendant phenoxy methyl-1,2,3-triazole: Design, synthesis and biological evaluation.

  2019cites this paper
• Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s disease

  2018cites this paper
• Synthesis and structure-activity relationship study of multi-target triazine derivatives as innovative candidates for treatment of Alzheimer's disease.

  2018cites this paper
• Novel tetrahydrocarbazole benzyl pyridine hybrids as potent and selective butryl cholinesterase inhibitors with neuroprotective and β-secretase inhibition activities.

  2018cites this paper
• Synthesis, cytotoxic characterization, and SAR study of imidazo[1,2‐b]pyrazole‐7‐carboxamides

  2018cites this paper
• Rapid Synthesis of N-Alkyl-2-imino-2H-chromene-3-carboxamides Catalyzed by a Keplerate-type Giant Nanoporous Isopolyoxomolybdate

  2018cites this paper
• Synthesis and biological evaluation of quinazolinone-based hydrazones with potential use in Alzheimer's disease.

  2017cites this paper
• Potential anti-cholinesterase and β-site amyloid precursor protein cleaving enzyme 1 inhibitory activities of cornuside and gallotannins from Cornus officinalis fruits

  2017cites this paper
• BACE1 inhibitory activity and molecular docking analysis of meroterpenoids from Sargassum serratifolium.

  2017cites this paper
• Discovery of imidazopyridines containing isoindoline-1,3-dione framework as a new class of BACE1 inhibitors: Design, synthesis and SAR analysis.

  2017cites this paper
• Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease.

  2017cites this paper
• A quantum chemical approach towards understanding stability and tautomerism of 2-imino-2H-pyran derivatives

  2016cites this paper
• Development and Structural Modification of BACE1 Inhibitors

  2016influential citation
• Direct Construction of 2-Aryliminochromenes from Arynes, N,S-Keteneacetals, and DMF.

  2016cites this paper
• Design and synthesis of novel anti-Alzheimer's agents: Acridine-chromenone and quinoline-chromenone hybrids.

  2016cites this paper
• Novel Therapeutic Strategies for Dementia.

  2016cites this paper
• Discovery of polymethoxyflavones from black ginger (Kaempferia parviflora) as potential β-secretase (BACE1) inhibitors

  2016cites this paper
• 4-O-galloylalbiflorin discovered from Paeonia lactiflora Pall. is a potential β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor

  2016cites this paper
• 2-Imino 2H-chromene and 2-(phenylimino) 2H-chromene 3-aryl carboxamide derivatives as novel cytotoxic agents: synthesis, biological assay, and molecular docking study

  2016cites this paper
• An efficient three-component synthesis of coumarin-3- carbamides by use of Ni-NiO nanoparticles as magnetically separable catalyst

  2015cites this paper
• Hydroxycinnamic acid as a novel scaffold for the development of cyclooxygenase-2 inhibitors

  2015cites this paper
• Inhibition of Alzheimer’s BACE-1 by 2,6-dialkyl-4-chromon-3-yl-1,4-dihydropyridine-3,5-dicarboxylates

  2015cites this paper
• N‐(2‐(Piperazin‐1‐yl)phenyl)arylamide Derivatives as β‐Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four‐Component Reaction and Biological Evaluation

  2015cites this paper
• Inhibitors of Alzheimer’s BACE-1 with 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridine structure

  2015cites this paper
• Function and toxicity of amyloid beta and recent therapeutic interventions targeting amyloid beta in Alzheimer's disease.

  2015cites this paper
• Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development.

  2014cites this paper
• Pharmacogenomics in Drug Discovery and Development

  2014cites this paper
• Design and synthesis of novel 3,5-bis-N-(aryl/heteroaryl) carbamoyl-4-aryl-1,4-dihydropyridines as small molecule BACE-1 inhibitors.

  2013cites this paper
• Design, synthesis and biological evaluation of novel anti-cytokine 1,2,4-triazine derivatives.

  2013cites this paper